Literature DB >> 15923293

Monitoring STI prevalence using telephone surveys and mailed urine specimens: a pilot test.

E Eggleston1, C F Turner, S M Rogers, A Roman, W C Miller, M A Villarroel, L Ganapathi.   

Abstract

OBJECTIVES: This pilot test assessed the feasibility of a cost effective population based approach to STI monitoring using automated telephone interviews, urine specimen collection kits sent out and returned by US Postal Service mail, and monetary incentives to motivate participation.
METHODS: 100 residents of Baltimore, MD, USA, completed an automated telephone survey and agreed to mail in a urine specimen to be tested for chlamydia and gonorrhoea. Participants were paid dollar 10 for completing the survey and dollar 40 for mailing the specimen.
RESULTS: 86% of survey participants mailed in a urine specimen for testing.
CONCLUSIONS: Automated telephone surveys linked with testing of mailed-in urine specimens may be a feasible lower cost (relative to household surveys) method of estimating infection prevalences in a population.

Entities:  

Mesh:

Year:  2005        PMID: 15923293      PMCID: PMC1744988          DOI: 10.1136/sti.2004.011080

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  7 in total

1.  Community-based chlamydia and gonorrhea screening through the United States mail, San Francisco.

Authors:  Peter J Bloomfield; Charlotte Kent; Diane Campbell; Larry Hanbrook; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2002-05       Impact factor: 2.830

2.  Postal urine specimens: are they a feasible method for genital chlamydial infection screening?

Authors:  J Macleod; R Rowsell; P Horner; T Crowley; E O Caul; N Low; G D Smith
Journal:  Br J Gen Pract       Date:  1999-06       Impact factor: 5.386

3.  Home screening for chlamydial genital infection: is it acceptable to young men and women?

Authors:  J Stephenson; C Carder; A Copas; A Robinson; G Ridgway; A Haines
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

4.  Untreated gonococcal and chlamydial infection in a probability sample of adults.

Authors:  Charles F Turner; Susan M Rogers; Heather G Miller; William C Miller; James N Gribble; James R Chromy; Peter A Leone; Phillip C Cooley; Thomas C Quinn; Jonathan M Zenilman
Journal:  JAMA       Date:  2002-02-13       Impact factor: 56.272

5.  Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study.

Authors:  L Ostergaard; J K Møller; B Andersen; F Olesen
Journal:  BMJ       Date:  1996-11-09

6.  The prevalence of Chlamydia trachomatis infection in male undergraduates: a postal survey.

Authors:  K E Rogstad; S M Bates; S Partridge; G Kudesia; R Poll; M A Osborne; S Dixon
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

7.  Repeat chlamydia screening by mail, San Francisco.

Authors:  P J Bloomfield; K C Steiner; C K Kent; J D Klausner
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

  7 in total
  4 in total

1.  Examining mediators of child sexual abuse and sexually transmitted infections.

Authors:  Melissa A Sutherland
Journal:  Nurs Res       Date:  2011 Mar-Apr       Impact factor: 2.381

2.  Abuse experiences, substance use, and reproductive health in women seeking care at an emergency department.

Authors:  Melissa A Sutherland; Heidi Collins Fantasia; Natalie McClain
Journal:  J Emerg Nurs       Date:  2011-11-14       Impact factor: 1.836

3.  Urine-based testing for Chlamydia trachomatis among young adults in a population-based survey in Croatia: feasibility and prevalence.

Authors:  Ivana Božičević; Ivana Grgić; Snježana Židovec-Lepej; Jurja-Ivana Čakalo; Sanja Belak-Kovačević; Aleksandar Štulhofer; Josip Begovac
Journal:  BMC Public Health       Date:  2011-04-14       Impact factor: 3.295

Review 4.  Home-based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes.

Authors:  Muhammad S Jamil; Jane S Hocking; Heidi M Bauer; Hammad Ali; Handan Wand; Kirsty Smith; Jennifer Walker; Basil Donovan; John M Kaldor; Rebecca J Guy
Journal:  BMC Public Health       Date:  2013-03-04       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.